Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
DRTS · against 461 other Healthcare companies of similar size
Ranked #175 of 462 · scores higher than 62% of peers · safety percentile 65
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)49 peers with a safety percentile of 60–69, including DRTS · Click a bar to see the companies
A mix: stronger current ratio, but weaker beta than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | DRTS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 435 reported | 0.34× | 0.21× | 35% | 33% | |
| BetaLower is better · 436 reported | 1.21 | 0.49 | 17% | 33% | |
| Current ratioHigher is better · 448 reported | 11.09× | 2.88× | 89% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 1.1B USD | 100 | ||
| 4 | 1.0B USD | 99 | 35 | |
| 5 | 1.2B USD | 99 | ||
| 171 | 13.5B CNY (≈$1.9B) | 66 | 67 | |
| 172 | 1.5B USD | 66 | 59 | |
| 173 | 9.2B CNY (≈$1.3B) | 66 | 53 | |
| 174 | 10.2B CNY (≈$1.4B) | 66 | 69 | |
| 175 | 1.3B USD | 65 | 30 | |
| 176 | 5.3B CNY (≈$743M) | 65 | 65 | |
| 177 | 2.2B USD | 65 | 20 | |
| 178 | 12.6B CNY (≈$1.8B) | 65 | 72 | |
| 179 | 1.5B SGD (≈$1.1B) | 65 | 60 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score